{"id":31654,"date":"2026-06-05T21:34:13","date_gmt":"2026-06-05T20:34:13","guid":{"rendered":"https:\/\/www.dr-mfo.com\/?p=31654"},"modified":"2026-06-26T21:56:19","modified_gmt":"2026-06-26T20:56:19","slug":"yag-hayatta-kalma-mtf-lipofilling-basinc","status":"publish","type":"post","link":"https:\/\/www.dr-mfo.com\/tr\/fat-survival-mtf-lipofilling-pressure\/","title":{"rendered":"MTF Lipofilling'de Ya\u011f Ya\u015fam\u0131n\u0131 S\u00fcrd\u00fcrme: Ya\u011f Toplama Bas\u0131nc\u0131 ve Tutulumu"},"content":{"rendered":"

What if the single greatest threat to your y\u00fcz feminizasyonu<\/a> result is not your surgeon’s injection technique\u2014but the invisible pressure inside the syringe used to harvest your fat? Consider this: a typical handheld syringe generates aspiration pressures between 700 and 900 mmHg of negative pressure. That vacuum force ruptures adipocyte cell membranes on contact, killing up to 40% of your graft before it ever touches your face. Now contrast that with low-pressure liposuction<\/a> at 250 mmHg, where adipocyte viability consistently exceeds 80%. The difference is not marginal\u2014it is the difference between a midface that retains its volume at twelve months and one that deflates within a single season.<\/p>\n\n\n\n

Most discussions about facial lipofilling in transfeminine patients obsess over injection placement. Yet the science tells a different story: fat harvesting pressure determines graft survival more than any downstream variable. This article presents a controlled clinical comparison of syringe aspiration versus low-pressure liposuction harvesting on adipocyte viability in FFS facial ya\u011f a\u015f\u0131s\u0131<\/a>. We will link harvest pressure to 12-month volumetric retention using 3D imaging data, and provide surgeon-level injection technique guidelines\u2014micro-droplet, Coleman, and Snodell\u2014for maximizing fat graft survival specifically in MTF midface augmentation.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\n
\n

\u0130\u00e7indekiler<\/p>\n<\/span><\/div>\n